WealthCollab’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22K Sell
946
-33
-3% -$711 0.01% 352
2025
Q4
$19.6K Hold
979
0.01% 402
2025
Q3
$17.9K Sell
979
-125
-11% -$2.44K 0.01% 382
2025
Q2
$22.2K Hold
1,104
0.01% 314
2025
Q1
$20K Buy
1,104
+51
+5% +$914 0.01% 317
2024
Q4
$18.3K Hold
1,053
0.01% 332
2024
Q3
$20.3K Hold
1,053
0.01% 309
2024
Q2
$17.3K Hold
1,053
0.01% 317
2024
Q1
$16K Buy
1,053
+125
+13% +$1.96K 0.01% 336
2023
Q4
$14.9K Buy
+928
New +$13K 0.01% 329

Other funds holding INVA

WealthCollab's INVA Position: Q1 2026 in Review

WealthCollab reduced its Innoviva (INVA) stake by 3.4% in Q1 2026, selling an estimated $711 and leaving 946 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #352.

WealthCollab first reported a position in INVA in Q4 2023 and has held it in 10 quarters since. The position peaked at $22.2K in Q2 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • WealthCollab held 946 shares of Innoviva worth $22K as of Q1 2026.
  • WealthCollab sold 33 Innoviva shares in Q1 2026, an estimated $711.
  • Innoviva made up 0.01% of WealthCollab's portfolio in Q1 2026, its #352 holding.
  • WealthCollab first reported a position in Innoviva in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Innoviva position peaked at $22.2K in Q2 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.